← back to search
Zhiyan Qian
Novartis (Switzerland) · CH
Area of research
Oncology · Genetics
Research interest
Research interests include Essential thrombocythemia, Transgene, Polycythemia vera, Myelofibrosis, and Janus kinase 2.
h-index
—
citations
11
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression
PLoS ONE
2019
cited by
11
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
—
·
1
papers (2019–2019)
Bernd Kinzel
· Novartis (Switzerland)
1
papers (2019–2019)
Vincent Romanet
· Novartis (Switzerland)
1
papers (2019–2019)
Fabienne Baffert
· Novartis (Switzerland)
1
papers (2019–2019)
Thomas Radimerski
· Novartis (Switzerland)
1
papers (2019–2019)
Masato Murakami
· Novartis (Switzerland)
1
papers (2019–2019)
Emilie A. Chapeau
· Novartis (Switzerland)
1
papers (2019–2019)
Ralph Tiedt
· Yale Cancer Center
1
papers (2019–2019)
Francesco Hofmann
· Novartis (Switzerland)
1
papers (2019–2019)
Moriko Ito
· Novartis (Switzerland)
1
papers (2019–2019)
Matthias Mueller
· University Hospital Heidelberg
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Sabine Zumstein-Mecker
· Novartis (Switzerland)
1
papers (2019–2019)
Rita Andraos-Rey
· Novartis (Switzerland)
1
papers (2019–2019)
Violetta Powajbo
· Novartis (Switzerland)
1
papers (2019–2019)
Ernesto Bockamp
· Johannes Gutenberg University Mainz
1
papers (2019–2019)
Nicolas Ebel
· Novartis (Switzerland)
1
papers (2019–2019)
Emeline Mandon
· Novartis (Switzerland)
1
papers (2019–2019)
Miltos Kininis
· Novartis (Switzerland)
1
papers (2019–2019)
Leonid Eshkind
· Johannes Gutenberg University Mainz
1
papers (2019–2019)